Dr William F Dubbs, MD in Muskogee, OK - Surgery

Dr William F Dubbs, MD is a Surgery physician based in Muskogee, Oklahoma. Dr William F Dubbs is licensed to practice in Oklahoma (license number 17490) and his current practice location is 1011 Honor Heights Dr, Muskogee, Oklahoma. He can be reached at his office (for appointments etc.) via phone at (918) 683-3261.

NPI number for Dr William F Dubbs is 1457433229 and his current mailing address is 1011 Honor Heights Dr, Muskogee, Oklahoma. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1457433229.

Contact Information

	Dr William F Dubbs, MD
	1011 Honor Heights Dr, Muskogee, OK 74401-1318
	(918) 683-3261
	(918) 680-3648

Physician's Profile

Full Name	Dr William F Dubbs
Gender	Male
Speciality	Surgery
Location	1011 Honor Heights Dr, Muskogee, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1457433229
Provider Enumeration Date: 10/20/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr William F Dubbs such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1457433229	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208600000X	Surgery	17490 (Oklahoma)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr William F Dubbs is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr William F Dubbs, MD 1011 Honor Heights Dr, Muskogee, OK 74401-1318 Ph: (918) 683-3261	Dr William F Dubbs, MD 1011 Honor Heights Dr, Muskogee, OK 74401-1318 Ph: (918) 683-3261

News Archive

FDA approves TGM's hip and knee systems and related surgical instruments

China Kanghui Holdings, a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that the Company's wholly-owned subsidiary, TGM Medical, Inc., has received approvals from the Food and Drug Administration of the United States for its Helicon Hip System ("HHS"), Milestone Knee System ("MKS") and related surgical instruments.

Statins shown to reduce COVID-19 severity and lower mortality

Much attention has been focused on ways to reduce the deadly exaggeration of normal inflammatory reactions to this pathogen. A new research paper posted to the medRxiv* preprint server describes the alleviation of hyper-inflammatory phenomena following the administration of statins, drugs more widely known for their use in reducing blood cholesterol levels, to patients with COVID-19.

FDA grants Orphan Drug Designation to Advaxis' ADXS-HPV for HPV-associated head and neck cancer

Advaxis, Inc.,, a leader in developing the next generation of cancer immunotherapies, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated head and neck cancer.

NIH-funded study of weight loss in adults with type 2 diabetes finds no cardiovascular benefits

An intensive diet and exercise program resulting in weight loss does not reduce cardiovascular events such as heart attack and stroke in people with longstanding type 2 diabetes, according to a study supported by the National Institutes of Health.

Heterologous AstraZeneca and Pfizer vaccines induce strong immune response and T cell reactivity against multiple SARS-CoV-2 variants

Researchers from Germany recently analyzed a cohort of 26 individuals in the age range of 25 to 46 (median 30.5) years who had received a ChAdOx1 nCoV-19 prime vaccine followed by a BNT162b2 boost vaccine after a 56-day interval due to changing vaccine recommendations in Germany. There were 16 females and 10 males in the cohort, and they were assessed for immune responses, reactogenicity, and T cell reactivity. This study is published on the medRxiv* preprint server.

Surgery Doctors in Muskogee, OK

Jay Allen Gregory, M.D. Surgery Medicare: May Accept Medicare Assignments Practice Location: 333 S 38th St Ste D, Muskogee, OK 74401 Phone: 918-687-5304 Fax: 918-687-0178
Dr. Patrick James Ross, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Rockefeller Dr Ste 201, Muskogee, OK 74401 Phone: 918-682-4580 Fax: 918-681-4566
Mr. Kyle A Baer, PA-C Surgery Medicare: Not Enrolled in Medicare Practice Location: 1011 Honor Heights Dr, Muskogee, OK 74401 Phone: 918-577-3000
Dr. Timothy D. Robison, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 S 37th St, Muskogee, OK 74401 Phone: 918-683-8100 Fax: 918-683-8198
Sumit Kumar, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Rockefeller Dr Ste 201, Muskogee, OK 74401 Phone: 918-682-4580 Fax: 918-681-4566

Dr William F Dubbs, MD - Surgery in Muskogee, OK